CN Patent

CN113853197B — 一种吸入溶液药物组合物及其制备方法

Assigned to Sichuan Haisco Pharmaceutical Co Ltd · Expires 2022-08-30 · 4y expired

What this patent protects

一种吸入溶液药物组合物及其制备方法，所述组合物包含茚达特罗或其盐、pH调节剂和水，以及任选的渗透压调节剂、缓冲离子对，通过将各组分溶解于水中制得。该药物组合物适合于借助于雾化器而将活性物质形成气雾以在哮喘及COPD症状中以吸入方式对患者施用。

USPTO Abstract

一种吸入溶液药物组合物及其制备方法，所述组合物包含茚达特罗或其盐、pH调节剂和水，以及任选的渗透压调节剂、缓冲离子对，通过将各组分溶解于水中制得。该药物组合物适合于借助于雾化器而将活性物质形成气雾以在哮喘及COPD症状中以吸入方式对患者施用。

Drugs covered by this patent

Patent Metadata

Patent number
CN113853197B
Jurisdiction
CN
Classification
—
Expires
2022-08-30
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Haisco Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.